Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

ARX mutations are associated with variable clinical phenotypes. We report a new neurodegenerative phenotype associated with a known ARX mutation and causing early abnormal neurodevelopment, a complex movement disorder, and early infantile epileptic encephalopathy with a suppression-burst pattern (Ohtahara syndrome). A male infant presented at age 5 months with a dyskinetic movement disorder, which was initially diagnosed as infantile spasms. Clinical deterioration was accompanied by progressive cortical atrophy with a reduction in white matter volume and resulting in death in the first year of life; such a rapidly progressive and severe phenotype has not previously been described. ARX mutation testing should be undertaken in children aged less than 1 year with Ohtahara syndrome and a movement disorder, and in infants with unexplained neurodegeneration, progressive white matter loss, and cortical atrophy.

Original publication

DOI

10.1111/j.1469-8749.2009.03470.x

Type

Journal article

Journal

Dev Med Child Neurol

Publication Date

03/2010

Volume

52

Pages

305 - 307

Keywords

Atrophy, Cerebral Cortex, Child, Preschool, DNA Mutational Analysis, Dyskinesias, Homeodomain Proteins, Humans, Magnetic Resonance Imaging, Male, Nerve Degeneration, Phenotype, Point Mutation, Syndrome, Transcription Factors